Status:

UNKNOWN

CS Scar Impact on ART Outcomes

Lead Sponsor:

HealthPlus Fertility Center

Conditions:

Fertility Issues

Eligibility:

FEMALE

25-40 years

Brief Summary

CS scar impact on ART outcomes, Retrospective Cohort Study IVF outcome can be affected by the presence of caesarean section scar with or without defect in different ways

Detailed Description

CS scar impact on ART outcomes, Retrospective Cohort Study IVF outcome can be affected by the presence of caesarean section scar with or without defect in different ways; increase difficulty of embryo...

Eligibility Criteria

Inclusion

  • Age 25-40 years old.
  • Euploid embryo transfer.
  • Medically free
  • BMI less tha 30 kg/m2
  • Hormone therapy preparation for FET.

Exclusion

  • \- Exclusion criteria
  • Previous uterine scar other than cesarean section.
  • Congenital uterine abnormalities
  • Presence of intrauterine lesions e.g., polyp, fibroid,
  • Endometriosis or adenomyosis
  • Hydrosalpinx, Chronic endometritis

Key Trial Info

Start Date :

June 15 2023

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

January 1 2024

Estimated Enrollment :

510 Patients enrolled

Trial Details

Trial ID

NCT06021886

Start Date

June 15 2023

End Date

January 1 2024

Last Update

November 21 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

HealthPlus fertility Centre

Abu Dhabi, United Arab Emirates